ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga lifescience sdn. bhd. - adrenaline acid tartrate -

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 8mg/8ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline 1mg;   - solution for injection - 1mg/10ml - active: adrenaline 1mg   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite tartaric acid water for injection - adrenaline 1:10,000. an adjunct in the management of cardiac arrest.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 2 mg/ml (equivalent: noradrenaline (norepinephrine), qty 1 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - for the restoration of blood pressure in certain acute hypotensive states (e.g phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:300000 equivalent to 0.00061% w/v adrenaline acid tartrate; prilocaine hydrochloride 3%{relative} - solution for injection - 3 % - active: adrenaline acid tartrate 1:300000 equivalent to 0.00061% w/v adrenaline acid tartrate prilocaine hydrochloride 3%{relative} excipient: sodium chloride sodium metabisulfite water

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - adrenaline acid tartrate 0.002275%{relative} equivalent to adrenaline 1:80 000;  ;  ; lidocaine hydrochloride monohydrate 2.134%{relative} equivalent to 2.000% w/v anhydrous - solution for injection - active: adrenaline acid tartrate 0.002275%{relative} equivalent to adrenaline 1:80 000     lidocaine hydrochloride monohydrate 2.134%{relative} equivalent to 2.000% w/v anhydrous excipient: potassium metabisulfite sodium chloride sodium edetate sodium hydroxide water for injection

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:80000; lidocaine hydrochloride 2%;   - solution for injection - 2 % - active: adrenaline acid tartrate 1:80000 lidocaine hydrochloride 2%  

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:100000; lidocaine hydrochloride 2%;   - suspension for injection - 2 % - active: adrenaline acid tartrate 1:100000 lidocaine hydrochloride 2%  

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - adrenaline acid tartrate 10 µg/ml;  ;  ; articaine hydrochloride 40 mg/ml;   - solution for injection - 40mg/10µg per ml - active: adrenaline acid tartrate 10 µg/ml     articaine hydrochloride 40 mg/ml   excipient: sodium chloride sodium hydroxide sodium metabisulfite water for injection - septanest 1:100,000 is indicated for local or regional anaesthesia for both simple and complex dental procedures in adults, adolescents and children 4 years of age and older. septanest 1:100,000 is indicated only for dental procedures.